We built a bioreactor inspired by how the body moves blood through tissue.
Smooth, laminar, continuous, and bubble-free. Without impellers, whithout spargers.
This is the HTB and we are going to be at #BIO2026 making live demos.
We're bringing the HTB to BIO International #BIO2026 for the first time. Live demos with the real machine running on-site. 🚀
Booth 5735 | San Diego | June 22–25
We're bringing something new to BIO International Convention 2026.
Juan Martin Cabaleiro, Subhadeep Das, Faith Wallace-Gadsden, and Jean-Christophe Quillet will be there representing Stämm and running the first public demos of the HTB: our High-Throughput Bioprocessor live.
We’re redefining biomanufacturing. Today, we introduce the High-Throughput Bioprocessor (HTB), Stämm’s new automated platform to rethink biological scaling.
Con @mpeire y @nitaneise discutimos un modelo productivo nacional que nos permitiera industrializar (¿pero cuáles industrias?) y con @__Yuyo descubrimos que nuestras biotecnologías están madurando en el mejor momento histórico posible.
Federico Marque ( GridX Partner & COO) moderated a panel alongside @__Yuyo Llamazares (Stämm CEO), Román Ortega Bianchi (Head of BD), and Juan Martín Cabaleiro.
They shared lessons learned, milestones in Stämm's journey, and advice for those who are just starting on this path.
@dosinaga2@BumperCrop1 La idea principal es que el gas las haga flotar y sirvan como medio de transporte aéreo sustentable. Con ese agujero regulas la altura. Space cowboys
What does it take to build a deeptech company in LATAM?
At #DraperCygnusTechWeek, @__Yuyo , CEO of @StammBio, shared how they’re tackling AI transparency and scaling biomanufacturing from the region to the world.
📺 Full panel: https://t.co/ssCvKWHCWi
#Biotech#DeepTech
🧬 Big news for one of our portfolio companies: @StammBio just got a US patent for the core tech behind its Bioprocessor.
It’s a breakthrough in how some of the world’s most complex medicines are made.
Biotech infra, built from LatAm.
#DeepTech#Biotech
In deep tech, your goal can change — but your purpose must stay the same.
@__Yuyo shared at #DraperCygnusTechWeek how @StammBio is technology evolved, but the mission to reinvent drug manufacturing never did🚀
📺 Full panel: https://t.co/FpmpCatfDJ
#DeepTech#LatamVC